Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297

1.

Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years.

Palandri F, Santoro C, Carpenedo M, Cantoni S, Barcellini W, Carli G, Carrai V, Rossi E, Rivolti E, Lucchesi A, Rotondo F, Baldacci E, Auteri G, Sutto E, Di Pietro C, Catani L, Bartoletti D, De Stefano V, Ruggeri M, Mazzucconi MG, Cavo M, Rodeghiero F, Vianelli N.

Thromb Res. 2019 Nov 21;185:88-95. doi: 10.1016/j.thromres.2019.11.026. [Epub ahead of print]

PMID:
31783273
2.

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.

Sant'Antonio E, Guglielmelli P, Pieri L, Primignani M, Randi ML, Santarossa C, Rumi E, Cervantes F, Delaini F, Carobbio A, Betti S, Rossi E, Lavi N, Harrison CN, Curto-Garcia N, Gisslinger H, Gisslinger B, Specchia G, Ricco A, Vianelli N, Polverelli N, Koren-Michowitz M, Ruggeri M, Girodon F, Ellis M, Iurlo A, Mannelli F, Mannelli L, Sordi B, Loscocco GG, Cazzola M, De Stefano V, Barbui T, Tefferi A, Vannucchi AM.

Am J Hematol. 2019 Nov 12. doi: 10.1002/ajh.25677. [Epub ahead of print]

PMID:
31721282
3.

Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin.

Barbui T, Ghirardi A, Vannucchi AM, Marchetti M, De Stefano V; MPN-K authors.

Leukemia. 2019 Nov 7. doi: 10.1038/s41375-019-0616-4. [Epub ahead of print] No abstract available.

PMID:
31700081
4.

Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group.

Mora B, Guglielmelli P, Rumi E, Maffioli M, Barraco D, Rambaldi A, Caramella M, Komrokji RS, Kiladjian JJ, Gotlib J, Iurlo A, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Albano F, Benevolo G, Cavalloni C, Uccella S, Accetta R, Siracusa C, Agnoli S, Merli M, Barbui T, Bertù L, Cazzola M, Vannucchi AM, Passamonti F.

Am J Hematol. 2019 Oct 7. doi: 10.1002/ajh.25644. [Epub ahead of print] No abstract available.

PMID:
31588594
5.

Rationale and design of two prospective, multicenter, observational studies on reproductive outcome in women with recurrent failures after spontaneous or assisted conception: OTTILIA and FIRST registries.

Villani M, Baldini D, Totaro P, Larciprete G, Kovac M, Carone D, Passamonti SM, Permunian ET, Bartolotti T, Lojacono A, Cacciola R, Pinto GL, Bucherini E, De Stefano V, Lodigiani C, Lavopa C, Cho YS, Pizzicaroli C, Colaizzo D, Grandone E.

BMC Pregnancy Childbirth. 2019 Aug 13;19(1):292. doi: 10.1186/s12884-019-2444-y.

6.

Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience.

Teofili L, Valentini CG, Bianchi M, Pellegrino C, Bellesi S, Chiusolo P, Laurenti L, Innocenti I, De Stefano V, Bacigalupo A.

Vox Sang. 2019 Oct;114(7):762-768. doi: 10.1111/vox.12834. Epub 2019 Aug 11.

PMID:
31402471
7.

Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper.

Barbui T, De Stefano V, Falanga A, Finazzi G, Martinelli I, Rodeghiero F, Vannucchi AM, Barosi G.

Blood Cancer J. 2019 Aug 8;9(8):61. doi: 10.1038/s41408-019-0225-5.

8.

Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis.

Breccia M, Luciano L, Pugliese N, Rossi E, Tiribelli M, Scalzulli E, Bonifacio M, Martino B, Latagliata R, Benevolo G, Caocci G, Binotto G, Martinelli V, Cavo M, Pane F, De Stefano V, Foà R, Palandri F.

Ann Hematol. 2019 Aug;98(8):1933-1936. doi: 10.1007/s00277-019-03727-6. Epub 2019 Jun 14.

PMID:
31201513
9.

Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative.

Loscocco GG, Mannelli F, Guglielmelli P, Paoli C, Marone I, Cucci R, Coltro G, Sordi B, Albano F, Breccia M, De Stefano V, Finazzi G, Iurlo A, Martino B, Palandri F, Passamonti F, Siragusa S, Mannelli L, Fantoni D, Fazi P, Amadori S, Vignetti M, Barbui T, Vannucchi AM.

Am J Hematol. 2019 Jun 9. doi: 10.1002/ajh.25555. [Epub ahead of print] No abstract available.

PMID:
31179561
10.

Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.

Xu X, Guo X, De Stefano V, Silva-Junior G, Goyal H, Bai Z, Zhao Q, Qi X.

Hepatol Int. 2019 Jul;13(4):468-481. doi: 10.1007/s12072-019-09951-6. Epub 2019 Jun 7. Review.

PMID:
31175581
11.

Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients.

Mora B, Rumi E, Guglielmelli P, Barraco D, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Cavalloni C, Pietra D, Barbui T, Rotunno G, Cazzola M, Vannucchi AM, Giorgino T, Passamonti F.

Cancer Med. 2019 Aug;8(9):4089-4092. doi: 10.1002/cam4.2107. Epub 2019 Jun 7.

12.

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study.

Barbui T, Ghirardi A, Masciulli A, Carobbio A, Palandri F, Vianelli N, De Stefano V, Betti S, Di Veroli A, Iurlo A, Cattaneo D, Delaini F, Bonifacio M, Scaffidi L, Patriarca A, Rumi E, Casetti IC, Stephenson C, Guglielmelli P, Elli EM, Palova M, Bertolotti L, Erez D, Gomez M, Wille K, Perez-Encinas M, Lunghi F, Angona A, Fox ML, Beggiato E, Benevolo G, Carli G, Cacciola R, McMullin MF, Tieghi A, Recasens V, Marchetti M, Griesshammer M, Alvarez-Larran A, Vannucchi AM, Finazzi G.

Leukemia. 2019 Aug;33(8):1996-2005. doi: 10.1038/s41375-019-0487-8. Epub 2019 May 29.

PMID:
31142846
13.

Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis.

Ferrari A, Carobbio A, Masciulli A, Ghirardi A, Finazzi G, De Stefano V, Vannucchi AM, Barbui T.

Haematologica. 2019 Dec;104(12):2391-2399. doi: 10.3324/haematol.2019.221234. Epub 2019 May 23.

14.

Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax.

Innocenti I, Morelli F, Autore F, Tomasso A, Corbingi A, Bellesi S, Za T, De Stefano V, Laurenti L.

Leuk Lymphoma. 2019 Dec;60(12):3078-3080. doi: 10.1080/10428194.2019.1612063. Epub 2019 May 20. No abstract available.

PMID:
31106622
15.

Analysis of planning strategies in primary eyes gaining a line or more of visual acuity after topography-guided laser in situ keratomileusis.

De Stefano VS, Meister C, Ehlke GL, Krueger RR.

J Cataract Refract Surg. 2019 Mar;45(3):321-327. doi: 10.1016/j.jcrs.2018.10.040. Epub 2019 Feb 4.

PMID:
30733106
16.

Noninvasive Assessment of Corneal Crosslinking With Phase-Decorrelation Optical Coherence Tomography.

Blackburn BJ, Gu S, Ford MR, de Stefano V, Jenkins MW, Dupps WJ Jr, Rollins AM.

Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):41-51. doi: 10.1167/iovs.18-25535.

17.

Live human assessment of depth-dependent corneal displacements with swept-source optical coherence elastography.

De Stefano VS, Ford MR, Seven I, Dupps WJ Jr.

PLoS One. 2018 Dec 28;13(12):e0209480. doi: 10.1371/journal.pone.0209480. eCollection 2018.

18.

Epidemiology of Budd-Chiari syndrome: A systematic review and meta-analysis.

Li Y, De Stefano V, Li H, Zheng K, Bai Z, Guo X, Qi X.

Clin Res Hepatol Gastroenterol. 2019 Aug;43(4):468-474. doi: 10.1016/j.clinre.2018.10.014. Epub 2018 Dec 7.

PMID:
30528513
19.

Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?

Teofili L, Valentini CG, Rossi E, De Stefano V.

Leukemia. 2019 Jan;33(1):279-281. doi: 10.1038/s41375-018-0304-9. Epub 2018 Dec 5. No abstract available.

20.

Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera.

Barbui T, De Stefano V, Ghirardi A, Masciulli A, Finazzi G, Vannucchi AM.

Blood Cancer J. 2018 Nov 26;8(12):124. doi: 10.1038/s41408-018-0161-9. No abstract available.

21.

Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases.

De Stefano V, Rossi E, Carobbio A, Ghirardi A, Betti S, Finazzi G, Vannucchi AM, Barbui T.

Blood Cancer J. 2018 Nov 12;8(11):112. doi: 10.1038/s41408-018-0151-y.

22.

Identification of novel mutations in patients with fibrinogen disorders and genotype/phenotype correlations.

Chinni E, Tiscia G, Favuzzi G, Cappucci F, Malcangi G, Bagna R, Izzi C, Rizzi D, De Stefano V, Grandone E.

Blood Transfus. 2019 May;17(3):247-254. doi: 10.2450/2018.0123-18. Epub 2018 Oct 8.

23.

Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus.

Napolitano M, Saccullo G, Marietta M, Carpenedo M, Castaman G, Cerchiara E, Chistolini A, Contino L, De Stefano V, Falanga A, Federici AB, Rossi E, Santoro R, Siragusa S; Gruppo Italiano Malattie EMatologiche dell’Adulto (GIMEMA) Working Party on Thrombosis and Hemostasis; Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA) Working Party on Thrombosis and Haemostasis (see Appendix 1), De Stefano V, Falanga A, Tosetto A, Avvisati G, Carpenedo M, Federici AB, Marietta M, Napolitano M, Rossi E, Santoro C, Castaman G, Cerchiara E, Chistolini A, Contino L, Mazzucconi MG, Nichele I, Russo L, Santi R, Santoro RC, Siragusa S, Tagariello G.

Blood Transfus. 2019 May;17(3):171-180. doi: 10.2450/2018.0143-18. Epub 2018 Oct 24.

24.

Targeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasms.

Barbui T, Finazzi G, Vannucchi AM, De Stefano V.

Blood Cancer J. 2018 Nov 7;8(11):103. doi: 10.1038/s41408-018-0143-y. No abstract available.

25.

Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project.

Barraco D, Mora B, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Merli M, Pietra D, Barbui T, Rotunno G, Cazzola M, Giorgino T, Vannucchi AM, Passamonti F.

Blood Cancer J. 2018 Sep 21;8(10):89. doi: 10.1038/s41408-018-0128-x. No abstract available.

26.

Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis.

Bringhen S, Offidani M, Palmieri S, Pisani F, Rizzi R, Spada S, Evangelista A, Di Renzo N, Musto P, Marcatti M, Vallone R, Storti S, Bernardini A, Centurioni R, Aitini E, Palmas A, Annibali O, Angelucci E, Ferrando P, Baraldi A, Rocco S, Andriani A, Siniscalchi A, De Stefano V, Meneghini V, Palumbo A, Grammatico S, Boccadoro M, Larocca A.

Crit Rev Oncol Hematol. 2018 Oct;130:27-35. doi: 10.1016/j.critrevonc.2018.07.003. Epub 2018 Jul 18. Review.

PMID:
30196909
27.

Arterial thrombosis and cancer: the neglected side of the coin of Trousseau syndrome.

De Stefano V.

Haematologica. 2018 Sep;103(9):1419-1421. doi: 10.3324/haematol.2018.197814. No abstract available.

28.

Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation.

Ripani D, Caldarella C, Za T, Pizzuto DA, Rossi E, De Stefano V, Giordano A.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):116-128. doi: 10.1007/s00259-018-4108-y. Epub 2018 Jul 27.

PMID:
30054697
29.

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study.

Mohty M, Terpos E, Mateos MV, Cavo M, Lejniece S, Beksac M, Bekadja MA, Legiec W, Dimopoulos M, Stankovic S, Durán MS, De Stefano V, Corso A, Kochkareva Y, Laane E, Berthou C, Salwender H, Masliak Z, Pečeliūnas V, Willenbacher W, Silva J, Louw V, Nemet D, Borbényi Z, Abadi U, Pedersen RS, Černelč P, Potamianou A, Couturier C, Feys C, Thoret-Bauchet F, Boccadoro M; EMMOS Investigators.

Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e401-e419. doi: 10.1016/j.clml.2018.06.018. Epub 2018 Jun 25.

30.

Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018.

Finazzi G, De Stefano V, Barbui T.

Blood Cancer J. 2018 Jun 26;8(7):64. doi: 10.1038/s41408-018-0100-9. Review.

31.

Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms.

De Stefano V, Finazzi G, Barbui T.

Blood Cancer J. 2018 Jun 26;8(7):65. doi: 10.1038/s41408-018-0101-8.

32.

Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization.

Hohaus S, Tisi MC, Bartolomei F, Cuccaro A, Maiolo E, Alma E, D'Alò F, Bellesi S, Rossi E, De Stefano V.

Blood Cancer J. 2018 Jun 7;8(6):54. doi: 10.1038/s41408-018-0096-1. No abstract available.

33.

The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting.

De Stefano V, Rocca B, Tosetto A, Soldati D, Petrucci G, Beggiato E, Bertozzi I, Betti S, Carli G, Carpenedo M, Cattaneo D, Cavalca V, Dragani A, Elli E, Finazzi G, Iurlo A, Lanzarone G, Lissandrini L, Palandri F, Paoli C, Rambaldi A, Ranalli P, Randi ML, Ricco A, Rossi E, Ruggeri M, Specchia G, Timillero A, Turnu L, Vianelli N, Vannucchi AM, Rodeghiero F, Patrono C.

Blood Cancer J. 2018 Jun 1;8(6):49. doi: 10.1038/s41408-018-0078-3.

34.

Transient portal vein thrombosis in liver cirrhosis.

Qi X, Guo X, Yoshida EM, Méndez-Sánchez N, De Stefano V, Tacke F, Mancuso A, Sugawara Y, Yang SS, Teschke R, Arora A, Valla DC.

BMC Med. 2018 Jun 5;16(1):83. doi: 10.1186/s12916-018-1069-8. Review.

35.

Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis.

Li M, De Stefano V, Song T, Zhou X, Guo Z, Zhu J, Qi X.

Thromb Res. 2018 Jul;167:96-103. doi: 10.1016/j.thromres.2018.05.007. Epub 2018 May 8.

PMID:
29803161
36.

Custom air puff-derived biomechanical variables in a refractive surgery screening setting: Study from 2 centers.

De Stefano VS, Seven I, Randleman JB, Dupps WJ Jr.

J Cataract Refract Surg. 2018 May;44(5):589-595. doi: 10.1016/j.jcrs.2018.03.022.

37.

Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia.

Mora B, Giorgino T, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Cavalloni C, Barraco D, Pietra D, Barbui T, Rotunno G, Vannucchi AM, Passamonti F.

Leuk Res. 2018 Jun;69:100-102. doi: 10.1016/j.leukres.2018.04.012. Epub 2018 Apr 23. No abstract available.

PMID:
29734070
38.

Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project.

Mora B, Giorgino T, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Cavalloni C, Barraco D, Merli M, Pietra D, Casalone R, Barbui T, Rotunno G, Cazzola M, Vannucchi AM, Passamonti F.

Haematologica. 2018 Sep;103(9):e392-e394. doi: 10.3324/haematol.2017.185751. Epub 2018 Apr 5. No abstract available.

39.

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

De Stefano V, Carobbio A, Di Lazzaro V, Guglielmelli P, Iurlo A, Finazzi MC, Rumi E, Cervantes F, Elli EM, Randi ML, Griesshammer M, Palandri F, Bonifacio M, Hernandez-Boluda JC, Cacciola R, Miroslava P, Carli G, Beggiato E, Ellis MH, Musolino C, Gaidano G, Rapezzi D, Tieghi A, Lunghi F, Loscocco GG, Cattaneo D, Cortelezzi A, Betti S, Rossi E, Finazzi G, Censori B, Cazzola M, Bellini M, Arellano-Rodrigo E, Bertozzi I, Sadjadian P, Vianelli N, Scaffidi L, Gomez M, Cacciola E, Vannucchi AM, Barbui T.

Blood Cancer J. 2018 Feb 28;8(3):25. doi: 10.1038/s41408-018-0048-9.

40.

Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts.

Tefferi A, Mudireddy M, Mannelli F, Begna KH, Patnaik MM, Hanson CA, Ketterling RP, Gangat N, Yogarajah M, De Stefano V, Passamonti F, Rosti V, Finazzi MC, Rambaldi A, Bosi A, Guglielmelli P, Pardanani A, Vannucchi AM.

Leukemia. 2018 May;32(5):1200-1210. doi: 10.1038/s41375-018-0019-y. Epub 2018 Feb 2.

41.

A STARD-compliant prediction model for diagnosing thrombotic microangiopathies.

Ferraro PM, Lombardi G, Naticchia A, Sturniolo A, Zuppi C, De Stefano V, Bonelli P, Buonocore R, Cervellin G, Lippi G, Gambaro G.

J Nephrol. 2018 Jun;31(3):405-410. doi: 10.1007/s40620-018-0468-4. Epub 2018 Jan 20.

PMID:
29353400
42.

Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy.

Hohaus S, Tisi MC, Bellesi S, Maiolo E, Alma E, Tartaglia G, Corrente F, Cuccaro A, D'Alo' F, Basile U, Larocca LM, De Stefano V.

Cancer Med. 2018 Jan;7(1):270-281. doi: 10.1002/cam4.1166. Epub 2017 Dec 22.

43.

Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia.

Corrente F, Bellesi S, Metafuni E, Puggioni PL, Marietti S, Ciminello AM, Za T, Sorà F, Fianchi L, Sica S, De Stefano V, Chiusolo P.

Cytometry B Clin Cytom. 2018 May;94(3):468-476. doi: 10.1002/cyto.b.21605. Epub 2017 Dec 29.

44.

Hemocoagulase might not control but worsen gastrointestinal bleeding in an elderly patient with type II respiratory failure.

Qi X, Wang J, Yu X, De Stefano V, Li H, Wu C, Zeng Q, Zhang Y, Ren L, Lin H, Deng J, Guo X.

Transl Gastroenterol Hepatol. 2017 Sep 12;2:71. doi: 10.21037/tgh.2017.08.08. eCollection 2017.

45.

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

Cantoni S, Carpenedo M, Mazzucconi MG, De Stefano V, Carrai V, Ruggeri M, Specchia G, Vianelli N, Pane F, Consoli U, Artoni A, Zaja F, D'adda M, Visentin A, Ferrara F, Barcellini W, Caramazza D, Baldacci E, Rossi E, Ricco A, Ciminello A, Rodeghiero F, Nichelatti M, Cairoli R.

Am J Hematol. 2018 Jan;93(1):58-64. doi: 10.1002/ajh.24935. Epub 2017 Nov 9.

46.

Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study.

Zaccardi F, Rocca B, Rizzi A, Ciminello A, Teofili L, Ghirlanda G, De Stefano V, Pitocco D.

Nutr Metab Cardiovasc Dis. 2017 Oct;27(10):902-909. doi: 10.1016/j.numecd.2017.06.016. Epub 2017 Jul 8.

PMID:
28838851
47.

External validation of the DASH prediction rule: a retrospective cohort study.

Tosetto A, Testa S, Martinelli I, Poli D, Cosmi B, Lodigiani C, Ageno W, De Stefano V, Falanga A, Nichele I, Paoletti O, Bucciarelli P, Antonucci E, Legnani C, Banfi E, Dentali F, Bartolomei F, Barcella L, Palareti G.

J Thromb Haemost. 2017 Oct;15(10):1963-1970. doi: 10.1111/jth.13781. Epub 2017 Aug 23.

48.

Biomechanical Diagnostics of the Cornea.

De Stefano VS, Dupps WJ Jr.

Int Ophthalmol Clin. 2017 Summer;57(3):75-86. doi: 10.1097/IIO.0000000000000172. Review. No abstract available.

49.

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.

Passamonti F, Giorgino T, Mora B, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Caramazza D, Merli M, Pietra D, Casalone R, Rotunno G, Barbui T, Cazzola M, Vannucchi AM.

Leukemia. 2017 Dec;31(12):2726-2731. doi: 10.1038/leu.2017.169. Epub 2017 May 31.

PMID:
28561069
50.

Thrombocytosis in a patient with upper gastrointestinal bleeding.

Qi X, De Stefano V, Shao X, Guo X.

Intractable Rare Dis Res. 2017 Feb;6(1):69-71. doi: 10.5582/irdr.2016.01080.

Supplemental Content

Loading ...
Support Center